Cooper C. Collins
Chief Executive Officer, Pernix Therapeutics Holdings.
Companies
- TherapeuticsMD, Inc.Board member Mar 2, 2012 to now1
- Pernix Therapeutics HoldingsChief Strategic Officer Jul 25, 2013 to Apr 2, 20142
- Pernix Therapeutics HoldingsBoard member Mar 11, 2010 to Feb 5, 20143
- Pernix Therapeutics HoldingsChief executive officer Mar 11, 2010 to Feb 7, 20133
- Pernix Therapeutics HoldingsPresident Mar 11, 2010 to Feb 7, 20133
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- TherapeuticsMD, Inc. TXMD60,516 shares4$115.0K at $1.90Feb 18, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 18, 2025Exercised options 8,500 shares of TherapeuticsMD, Inc.4
- Aug 22, 2024Bought 4,094 shares at $1.73 of TherapeuticsMD, Inc.5
- Aug 21, 2024Bought 1,200 shares at $1.70 of TherapeuticsMD, Inc.6
- Aug 18, 2022Exercised options 1,984 shares of TherapeuticsMD, Inc.7
- Nov 18, 2021Bought 1,000,000 shares at $0.58 of TherapeuticsMD, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTherapeuticsMD, Inc., Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Aug 26, 2024
- 6SEC EDGARForm 4 filed Aug 23, 2024
- 7SEC EDGARForm 4 filed Aug 22, 2022
- 8SEC EDGARForm 4 filed Nov 22, 2021